(IBHH) iShares iBonds 2028 Term - Ratings and Ratios
High-Yield, Corporate, Bonds, 2028, Maturity
Description: IBHH iShares iBonds 2028 Term October 28, 2025
The iShares iBonds 2028 Term High Yield and Income ETF (BATS:IBHH) tracks an index of U.S.-dollar-denominated, taxable, fixed-rate corporate bonds that are rated high-yield or BBB (or equivalent) and have maturities strictly between January 1 2028 and December 15 2028. To fully replicate the index, the fund may also hold bonds issued by non-U.S. entities, and it is classified as a non-diversified ETF.
As of the most recent data (Q3 2024), the fund’s weighted average maturity is 2.9 years, and its effective duration sits around 2.5, reflecting modest interest-rate sensitivity. The current yield-to-worst is approximately 5.8%, which is roughly 1.2 percentage points above the Bloomberg U.S. Treasury 2-year benchmark, indicating a credit spread premium that compensates investors for higher default risk.
Key macro drivers for IBHH’s performance include the Federal Reserve’s policy trajectory and the broader economic cycle. A tightening cycle that pushes the Fed funds rate above 5% would likely compress high-yield spreads, while a recession-induced slowdown in corporate earnings could widen defaults and widen spreads, especially in cyclical sectors such as energy and consumer discretionary, which together account for about 30% of the portfolio’s weight.
Given its non-diversified status, concentration risk is a material consideration; the top five issuers represent roughly 18% of assets, so investors should monitor issuer-specific credit developments closely.
For a deeper, data-driven assessment of IBHH’s risk-adjusted return profile, you might explore the ValueRay platform’s interactive credit-spread analytics.
IBHH ETF Overview
| Market Cap in USD | 348m |
| Category | Target Maturity |
| TER | 0.35% |
| IPO / Inception | 2022-03-08 |
IBHH ETF Ratings
| Growth Rating | 78.2% |
| Fundamental | - |
| Dividend Rating | 70.5% |
| Return 12m vs S&P 500 | -6.72% |
| Analyst Rating | - |
IBHH Dividends
| Dividend Yield 12m | 6.55% |
| Yield on Cost 5y | 7.91% |
| Annual Growth 5y | 16.92% |
| Payout Consistency | 100.0% |
| Payout Ratio | % |
IBHH Growth Ratios
| Growth Correlation 3m | 72.1% |
| Growth Correlation 12m | 92.4% |
| Growth Correlation 5y | 93.7% |
| CAGR 5y | 9.16% |
| CAGR/Max DD 3y (Calmar Ratio) | 1.94 |
| CAGR/Mean DD 3y (Pain Ratio) | 12.38 |
| Sharpe Ratio 12m | 1.21 |
| Alpha | -5.12 |
| Beta | 0.570 |
| Volatility | 3.20% |
| Current Volume | 45.3k |
| Average Volume 20d | 61.5k |
| Stop Loss | 22.9 (-3%) |
| Signal | 0.78 |
What is the price of IBHH shares?
Over the past week, the price has changed by +0.04%, over one month by -0.13%, over three months by +1.40% and over the past year by +7.07%.
Is iShares iBonds 2028 Term a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBHH is around 24.22 USD . This means that IBHH is currently overvalued and has a potential downside of 2.58%.
Is IBHH a buy, sell or hold?
What are the forecasts/targets for the IBHH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 26.9 | 14% |
IBHH Fundamental Data Overview October 27, 2025
Beta = 0.57
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 348.5m USD (348.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 348.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 348.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.12% (E(348.5m)/V(348.5m) * Re(8.12%) + (debt-free company))
Discount Rate = 8.12% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBHH ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle